Literature DB >> 15812369

Screening for coronary heart disease: cardiology through the oncology looking glass.

D Douglas Miller1, Leslee J Shaw.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15812369     DOI: 10.1016/j.nuclcard.2004.12.292

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  42 in total

1.  Coronary artery calcium and cardiac events: is electron-beam tomography ready for prime time?

Authors:  William S Weintraub
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

2.  Prostate cancers in men with low PSA levels--must we find them?

Authors:  H Ballentine Carter
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

3.  Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.

Authors: 
Journal:  J Chronic Dis       Date:  1977-05

Review 4.  Screening for breast cancer: a review.

Authors:  A B Miller
Journal:  Eur J Cancer Clin Oncol       Date:  1988-01

5.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

6.  A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort.

Authors:  A Peeters; A A Mamun; F Willekens; L Bonneux
Journal:  Eur Heart J       Date:  2002-03       Impact factor: 29.983

7.  Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

Review 8.  The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

Authors:  Thomas J Wang; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

9.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

10.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more
  1 in total

1.  Screening the population for coronary artery disease: is it like screening for cancer?

Authors:  Prem Soman; James E Udelson
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.